A bivalent Lassa virus mRNA vaccine protects guinea pigs from lethal infection with Lassa virus
Lassa virus (LASV), the causative agent of the life-threatening febrile disease, Lassa fever, remains a major public health concern in West Africa, where hundreds of thousands of infections occur annually. However, no licensed vaccine is currently available, highlighting the urgent need for effective preventive measures. We previously demonstrated that an mRNA-lipid nanoparticle (LNP) vaccine…
We haven't written up this one. bioRxiv has the full story — the link below goes straight to it.
